| [1] |
National Institute for Health and Care Excellence (NICE). COVID-19 rapid guideline: chronic kidney disease[EB/OL]. 2020. https://www.ncbi.nlm.nih.gov/books/NBK566142/. |
| [2] |
Palevsky PM, Radhakrishnan J, Townsend RR. COVID-19: issues related to acute kidney injury, glomerular disease, and hypertension[EB/OL]. 2022. https://www.uptodate.com/contents/covid-19-issues-related-to-acute-kidney-injury-glomerular-disease-and-hypertension#!. |
| [3] |
Palevsky PM, Radhakrishnan J. COVID-19: issues related to end-stage kidney disease[EB/OL]. 2022. https://www.uptodate.com/contents/covid-19-issues-related-to-end-stage-kidney-disease#!. . |
| [4] |
国家卫生健康委办公厅, 国家中医药局综合司. 新型冠状病毒感染诊疗方案(试行第十版)[EB/OL]. 2023. http://www.gov.cn/zhengce/zhengceku/2023-01/06/57353 43/files/5844ce04246b431dbd322d8ba10afb48.pdf. |
| [5] |
Georgiades CS, Moore CJ, Smith DP. Differences of renal parenchymal attenuation for acutely obstructed and unobstructed kidneys on unenhanced helical CT: a useful secondary sign?[J]. AJR Am J Roentgenol, 2001, 176(4): 965-968.
doi:10.2214/ajr.176.4.1760965URL |
| [6] |
Li Z, Wu M, Yao JW, et al. Caution on kidney dysfunctions of COVID-19 patients[EB/OL]. 2020. https://www.medrxiv.org/content/10.1101/2020.02.08.20021212v2. |
| [7] |
Murakami N, Hayden R, Hills T, et al. Therapeutic advances in COVID-19[J]. Nat Rev Nephrol, 2023, 19(1):38-52.
doi:10.1038/s41581-022-00642-4URL |
| [8] |
Hiremath S, McGuinty M, Argyropoulos C, et al. Prescribing nirmatrelvir/ritonavir for COVID-19 in advanced CKD[J]. Clin J Am Soc Nephrol, 2022, 17(8):1247-1250.
doi:10.2215/CJN.05270522URL |
| [9] |
El Karoui K, De Vriese AS. COVID-19 in dialysis: clinical impact, immune response, prevention, and treatment[J]. Kidney Int, 2022, 101(5): 883-894.
doi:10.1016/j.kint.2022.01.022pmid:35176326 |
| [10] |
Leventhal J, Angeletti A, Cravedi P. EPO in patients with COVID-19: more than an erythropoietic hormone[J]. Am J Kidney Dis, 2020, 76(3): 441.
doi:S0272-6386(20)30749-6pmid:32534130 |
| [11] |
Caplin NJ, Zhdanova O, Tandon M, et al. Acute peritoneal dialysis during the COVID-19 pandemic at Bellevue Hospital in New York City[J]. Kidney360, 2020, 1(12): 1345-1352.
doi:10.34067/KID.0005192020URL |
| [12] |
Soomro QH, Mukherjee V, Amerling R, et al. Case series of acute peritoneal dialysis in the prone position for acute kidney injury during the Covid-19 pandemic: prone to complications?[J]. Perit Dial Int, 2021, 41(3): 328-332.
doi:10.1177/0896860820983670URL |
| [13] |
Ronco C, Reis T, Husain-Syed F. Management of acute kidney injury in patients with COVID-19[J]. Lancet Respir Med, 2020, 8(7): 738-742.
doi:10.1016/S2213-2600(20)30229-0pmid:32416769 |
